Pregnant people can safely take Paxlovid to reduce the possi

Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.

Related Keywords

, Irina Burd , Kimberly Jones Beatty , Sabra Klein , Emily Henderson , Heba Mostafa , William Garneau , Michelle Ufua , Kelly Gebo , Johns Hopkins Institute For Clinical , Network Openprovide , Department Of Obstetrics , Drug Administration , Lab Diagnostics Automation , Reproductive Sciences , Johns Hopkins University School Of Medicine , Lab Diagnostics Automation Industry , National Institutes Of Health Center , Johns Hopkins Health Systems , American College Of Obstetricians , University Of Maryland School Medicine , Society For Maternal , Translational Research , Roadmap For Medical Research , Johns Hopkins Medicine , Assistant Professor , Johns Hopkins University School , Maryland School , Automation Industry Focus , Maternal Fetal Medicine , American College , Johns Hopkins , Johns Hopkins Institute , National Institutes , National Center , Advancing Translational Science , Allergy , Antiviral Drug , Covid 19 , Drugs , Efficacy , Ynecology , Infectious Diseases , Medicine , Obstetrics , Pregnancy , Research , Cars , Ars Cov 2 , Virus ,